Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer-Reference-Cited by-同舟云学术

Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer

Published:2017-02 Issue:7641 Volume:542 Page:362-366
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Genovese Giannicola,Carugo Alessandro,Tepper James,Robinson Frederick Scott,Li Liren,Svelto Maria,Nezi Luigi,Corti Denise,Minelli Rosalba,Pettazzoni Piergiorgio,Gutschner Tony,Wu Chia-Chin,Seth Sahil,Akdemir Kadir Caner,Leo Elisabetta,Amin Samirkumar,Molin Marco Dal,Ying Haoqiang,Kwong Lawrence N.,Colla Simona,Takahashi Koichi,Ghosh Papia,Giuliani Virginia,Muller Florian,Dey Prasenjit,Jiang Shan,Garvey Jill,Liu Chang-Gong,Zhang Jianhua,Heffernan Timothy P.,Toniatti Carlo,Fleming Jason B.,Goggins Michael G.,Wood Laura D.,Sgambato Alessandro,Agaimy Abbas,Maitra Anirban,Roberts Charles W. M.,Wang Huamin,Viale Andrea,DePinho Ronald A.,Draetta Giulio F.,Chin Lynda

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature21064.pdf

Reference58 articles.

1. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011)

2. Nieto, M. A., Huang, R. Y., Jackson, R. A. & Thiery, J. P. Emt: 2016. Cell 166, 21–45 (2016)

3. Pisco, A. O. & Huang, S. Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: ‘What does not kill me strengthens me’. Br. J. Cancer 112, 1725–1732 (2015)

4. Rhim, A. D. et al. EMT and dissemination precede pancreatic tumor formation. Cell 148, 349–361 (2012)

5. Kopp, J. L. et al. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell 22, 737–750 (2012)

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The KRAS mutational spectrum and its clinical implications in pancreatic cancer;Cancer Cell;2024-09

2. Discovery of Novel, Potent and Orally Bioavailable SMARCA2 PROTACs with Synergistic Anti-tumor Activity in Combination with KRAS G12C Inhibitors;2024-08-26

3. Upregulated Matrisomal Proteins and Extracellular Matrix Mechanosignaling Underlie Obesity-Associated Promotion of Pancreatic Ductal Adenocarcinoma;Cancers;2024-04-21

4. The protein phosphatase-2A subunit PR130 is involved in the formation of cytotoxic protein aggregates in pancreatic ductal adenocarcinoma cells;Cell Communication and Signaling;2024-04-03

5. An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer;Cell Reports Medicine;2024-02